Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

Patients with chronic kidney disease (CKD) who receive a gadolinium-based contrast agent (GBCA) have a low risk of developing nephrogenic systemic fibrosis (NSF), a systematic review and meta-analysis ...

A magnetic resonance imaging (MRI) scan is an important tool to help doctors see what’s happening inside your body. But new, preliminary research suggests that a contrast agent used in some MRIs could ...

DEAR DR. ROACH: I am 70. Due to breast cancer history in my family and a diagnosis of atypical ductal hyperplasia in a lump that was removed, I get MRIs with and without imaging agents annually. Do I ...

A new study has found why MRI scans may leave harmful metals behind in a person's body. The University of New Mexico (UNM) study explored health risks caused by toxic rare earth metal gadolinium, ...

The volume of contrast media used for diagnostic imaging, including iodinated and gadolinium agents, has increased in recent years.

Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces that on 11 December 2025 the Committee for Medicinal ...

New research suggests that MRI with contrast may create nanoparticles that infiltrate your tissues. The research is preliminary, and more work needs to be done. Doctors stress that MRI with contrast ...